CBio Limited
Queensland, AU· latest recorded location
CBio Limited is named on 8 US grants and 10 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 8
- Published applications
- 10
- Inventors
- 21
- Granted in 2026 so far
- 0
- Most recent grant
- 4 Oct 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 3 |
| 2010 | 0 | 1 |
| 2011 | 3 | 2 |
| 2012 | 0 | 2 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 1 | 1 |
| 2016 | 2 | 0 |
By publication year.
Technology areas
Share of 18 documents
Recent patents
- Chaperonin 10-induced immunomodulation4 Oct 2016US 9,457,062 B2
- Modified Cpn10 and PRR signalling12 Jan 2016US 9,234,019 B2
- Chaperonin 10 variants13 Jan 2015US 8,933,033 B2
- Regulation of immune responses by modulation of the function of antigen presenting cells5 Aug 2014US 8,796,225 B2
- Chaperonin 10 immunosuppression29 Nov 2011US 8,067,361 B2
- Chaperonin 10 variants1 Oct 2015US 2015/0274794 A1
- Chaperonin 10 variants27 Dec 2012US 2012/0328635 A1
- Modified chaperonin 1019 Jan 2012US 2012/0014998 A1
- Prevention and treatment of cutaneous lupus erythematosus6 Oct 2011US 2011/0243921 A1
- Modified Cpn10 and PRR signalling7 Apr 2011US 2011/0082073 A1
Most cited
By later US patents